Rapamycin inhibition of CFA-induced lymphangiogenesis in PLN is independent of mast cells

Mol Biol Rep. 2014;41(4):2217-28. doi: 10.1007/s11033-014-3073-1. Epub 2014 Jan 14.

Abstract

Elucidation of the events responsible for the interaction between lymphatic endothelial cells (LECs) and mast cells (MCs) may prove to be a valuable source for controlling lymphangiogenesis. In the present study, we compared immunohistochemical and RT-PCR findings of the popliteal lymph node (PLN) and footpad skin in C57BL/6J and WBB6F1 mice, the MC-deficient strain. The results indicated that MCs play certain role in complete Freund's adjuvant-induced intranodal lymphangiogenesis. VEGF-A, VEGFR-2 and TNF-α were crucial factors in lymphangiogenesis both in the PLN and skin. Moreover, the in vivo administration of the specific mTOR inhibitor, rapamycin inhibited lymphangiogenesis independent of MCs in PLN rather than in the skin. Further study on anti-lymphangiogenic effect will contribute to our understanding of LEC and MC modulation in pathological lymphangiogenesis.

MeSH terms

  • Animals
  • Female
  • Freund's Adjuvant / pharmacology*
  • Immunohistochemistry
  • Lymph Nodes / cytology
  • Lymph Nodes / drug effects*
  • Lymph Nodes / metabolism*
  • Lymphangiogenesis / drug effects*
  • Mast Cells / metabolism*
  • Mice
  • Sirolimus / pharmacology*
  • Skin / metabolism
  • Skin / ultrastructure

Substances

  • Freund's Adjuvant
  • Sirolimus